Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

TiGenix NV - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 29 | Code: MRS - 18606


Global Markets Directs, TiGenix NV Product Pipeline Review 2014, provides an overview of the TiGenix NVs pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of TiGenix NVs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides brief overview of TiGenix NV including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of TiGenix NVs human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the TiGenix NVs pipeline products

Reasons to buy

Evaluate TiGenix NVs strategic position with total access to detailed information on its product pipeline
Assess the growth potential of TiGenix NV in its therapy areas of focus
Identify new drug targets and therapeutic classes in the TiGenix NVs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of TiGenix NV and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of TiGenix NV
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of TiGenix NV and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table Of Content 

Table of Contents 2
List of Tables 3
List of Figures 3
TiGenix NV Snapshot 4
TiGenix NV Overview 4
Key Information 4
Key Facts 4
TiGenix NV- Research and Development Overview 5
Key Therapeutic Areas 5
TiGenix NV- Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products- Monotherapy 8
TiGenix NV- Pipeline Products Glance 9
TiGenix NV- Late Stage Pipeline Products 9
Phase III Products/Combination Treatment Modalities 9
TiGenix NV- Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Phase I Products/Combination Treatment Modalities 11
TiGenix NV- Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
TiGenix NV- Drug Profiles 13
Cx-601 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Cx-611 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Cx-602 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Cx-603 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Cx-911 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
TiGenix NV.- Pipeline Analysis 20
TiGenix NV- Pipeline Products by Route of Administration 20
TiGenix NV- Pipeline Products by Molecule Type 21
TiGenix NV- Recent Pipeline Updates 22
TiGenix NV- Dormant Projects 25
TiGenix NV- Discontinued Pipeline Products 26
Discontinued Pipeline Product Profiles 26
Cx-501 26
TiGenix NV- Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27

Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 29
Disclaimer 29

List of Tables

TiGenix NV, Key Information 4
TiGenix NV, Key Facts 4
TiGenix NV- Pipeline by Indication, 2014 6
TiGenix NV- Pipeline by Stage of Development, 2014 7
TiGenix NV- Monotherapy Products in Pipeline, 2014 8
TiGenix NV- Phase III, 2014 9
TiGenix NV- Phase II, 2014 10
TiGenix NV- Phase I, 2014 11
TiGenix NV- Preclinical, 2014 12
TiGenix NV- Pipeline by Route of Administration, 2014 20
TiGenix NV- Pipeline by Molecule Type, 2014 21
TiGenix NV- Recent Pipeline Updates, 2014 22
TiGenix NV- Dormant Developmental Projects,2014 25
TiGenix NV- Discontinued Pipeline Products, 2014 26
TiGenix NV, Subsidiaries 27

List of Figures

TiGenix NV - Pipeline by Top 10 Indication, 2014 6
TiGenix NV - Pipeline by Stage of Development, 2014 7
TiGenix NV - Monotherapy Products in Pipeline, 2014 8
TiGenix NV - Pipeline by Top 10 Route of Administration, 2014 20
TiGenix NV - Pipeline by Top 10 Molecule Type, 2014 21

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing